Sarepta Therapeutics, Inc.
(NASDAQ : SRPT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
1.11%171.581.3%$500.69m
BIIBBiogen Inc.
1.00%235.241.3%$484.05m
CELGCelgene Corporation
0.13%96.371.3%$469.21m
GILDGilead Sciences, Inc.
-0.02%66.510.9%$452.08m
ILMNIllumina, Inc.
2.24%313.333.5%$316.73m
REGNRegeneron Pharmaceuticals, Inc.
3.38%320.422.6%$294.11m
AAgilent Technologies, Inc.
-0.52%67.971.6%$198.93m
VRTXVertex Pharmaceuticals Incorporated
2.03%172.561.9%$181.19m
EXASExact Sciences Corporation
-1.88%95.1325.3%$167.62m
ALXNAlexion Pharmaceuticals, Inc.
-0.96%127.562.0%$149.99m
BMRNBioMarin Pharmaceutical Inc.
0.41%87.834.3%$118.19m
SRPTSarepta Therapeutics, Inc.
0.40%121.6714.7%$115.94m
INCYIncyte Corporation
0.63%79.182.5%$107.42m
IONSIonis Pharmaceuticals, Inc.
-1.01%68.548.2%$98.35m
ALNYAlnylam Pharmaceuticals, Inc
0.15%67.979.2%$95.76m

Company Profile

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.